The Trump administration is proposing small pay increases for Medicare Advantage plans of less than 0.1% on average through 2027, far less than industry expectations.[1][3] The Centers for Medicare and Medicaid Services (CMS) plans to eliminate twelve quality measures for evaluating Medicare Advantage plans, including measures related to attrition, customer service, and quality of health care.[1][3] The administration decided not to move forward with a Biden-era initiative that would have rewarded insurance companies for improving the health of low-income and disabled policyholders beginning in 2027.[1] These star rating changes are projected to cost taxpayers about $13.2 billion between 2028 and 2036, or about 0.1% of the payment volume for health plans over that period.[1][3] Eliminating the twelve indicators should lower plan ratings overall, but eliminating the health equity program could allow them to score higher, according to CMS projections.[1] CMS proposes to introduce a new indicator for screening patients for depression with subsequent follow-up for evaluations in 2029.[1]